Fact sheet: Intl Biotechnology Trust

Fund information

Fund name
International Biotechnology Trust
Fund company manager
SV Life Sciences Managers
Fund type
ITR
Fund manager
David Pinniger
since 01/04/2008
Fund objective
The investment objective of International Biotechnology Trust plc (the “Company”) is to achieve long-term capital growth by investing primarily in biotechnology and other life sciences companies that are either quoted or unquoted and possess the potential for high growth. The Company invests in companies whose shares are considered to have good prospects, with experienced management and strong potential upside through the development and/or commercialization of a product, device or enabling technology.
Benchmark
NASDAQ Biotechnology
Investment style
-
Investment method
-

Performance snapshot

Quick stats

1 Year return

19.82 %

1 Year rank in sector

1/4

Sector

IT Biotechnology & Healthcare

Yield

3.8017

Fund size

£ 227.2 m

FE Risk score

196

NAV

635.17

Discount/Premium

+-4.7499

Gearing

100

Top in sector

Holdings snapshot

  • North America
    83%
  • Europe
    17%
  • North American Equities
    83%
  • European Equities
    17%

Performance vs. Sector

Cumulative performance

1m6m1y3y5y
Fund4 %3.46 %19.82 %97.39 %199.84 %
Sector1.59 %3.87 %13.61 %62.14 %166.01 %
Rank within sector2 / 63 / 51 / 41 / 42 / 4
Quartile th2 nd3 rd1 st1 st2 nd

Calendar performance

YTD-20172016201520142013
Fund14.49 %1.62 %22.18 %48.16 %49.5 %
Sector12.88 %6.22 %12.73 %39.34 %43.24 %
Rank within sector3 / 53 / 41 / 41 / 42 / 4
Quartile th3 rd3 rd1 st1 st2 nd

Risk statistics

Alpha0.22
Beta1.39
Sharpe0.85
Volatility27.91
Tracking error11.02
Information ratio0.55
R-Squared0.91

Price movement

52 week high633.5
52 week low504.75
Current bid price603
Current offer price607
Current mid price605

Holdings by region

  • 83% North America
  • 17% Europe

Holdings by sector

-

Holdings by asset type

  • 83% North American Equities
  • 17% European Equities

Individual holdings

  • 7.6% CELGENE CORP
  • 6.6% REGENERON PHARMACEUTICALS INC
  • 5.4% BIOGEN INC
  • 5% GENMAB AS
  • 4.3% VERTEX PHARMACEUTICAL
  • 3.9% GILEAD INC
  • 3.7% ALEXION PHARMACEUTICALS INC
  • 3.2% BIOMARIN PHARMACEUTICAL
  • 3.2% INCYTE CORP
  • 2.8% AMGEN INC